The percentage of CD4+CD25+ Treg cells was significantly increased in NSCLC patients (24.81 ± 1%) compared to HD (14.67 ± 1.5%; p = 0.0002; Fig. 1A). This evidence concerns the gene CD4 and non-small cell lung carcinoma.